Use of medicines with unknown fetal risk among parturient women from the 2004 Pelotas birth cohort (Brazil)

Journal of Pregnancy

Volumn 2012, Issue , 2012, Pages

  Bertoldi, Andréa Dâmaso ^a   Dal Pizzol, Tatiane Da Silva ^b   Camargo, Aline Lins ^c   Barros, Aluísio J D ^a   Matijasevich, Alicia ^a   Santos, Iná S ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAZIL; COHORT ANALYSIS; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HUMAN; PREGNANCY; QUESTIONNAIRE; RISK; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS;

ADULT; BRAZIL; COHORT STUDIES; DRUG UTILIZATION; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; PREGNANCY; QUESTIONNAIRES; RISK; SOCIOECONOMIC FACTORS;

MLCS; MLOWN;

EID: 84872764185     PISSN: 20902727     EISSN: 20902735     Source Type: Journal    
DOI: 10.1155/2012/257597     Document Type: Article

References (43)

1. Andrade S. E., Gurwitz J. H., Davis R. L., Chan K. A., Finkelstein J. A., Fortman K., McPhillips H., Raebel M. A., Roblin D., Smith D. H., Yood M. U., Morse A. N., Platt R., Prescription drug use in pregnancy. American Journal of Obstetrics and Gynecology 2004 191 2 398 407 2-s2.0-4444259620 10.1016/j.ajog.2004.04.025 (Pubitemid 39178690)
2. Bakker M. K., Jentink J., Vroom F., van den Berg P. B., de Walle H. E. K., de Jong-Van den Berg L. T. W., Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. International Journal of Obstetrics and Gynaecology 2006 113 5 559 568 2-s2.0-33645974873 10.1111/j.1471-0528.2006.00927.x
3. Engeland A., Bramness J. G., Daltveit A. K., Rønning M., Skurtveit S., Furu K., Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. British Journal of Clinical Pharmacology 2008 65 5 653 660 2-s2.0-42149191886 10.1111/j.1365-2125.2008.03102.x (Pubitemid 351535090)
4. Costa da Fonseca M. R. C., da Fonseca E., Bergsten-Mendes G., Prevalence of drug use during pregnancy: a pharmacoepidemiological approach. Revista de Saude Publica 2002 36 2 205 212 2-s2.0-0036307132 (Pubitemid 34746093)
5. Gagne J. J., Maio V., Berghella V., Louis D. Z., Gonnella J. S., Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. European Journal of Clinical Pharmacology 2008 64 11 1125 1132 2-s2.0-55349147292 10.1007/s00228-008-0546-y
6. Geib L. T. C., Vargas Filho E. F., Geib D., Mesquita D. I., Nunes M. L., Prevalence and determinants of medication during pregnancy by risk class among mothers of liveborn infants. Cadernos de Saude Publica 2007 23 10 2351 2362 2-s2.0-35648999963
7. Kebede B., Gedif T., Getachew A., Assessment of drug use among pregnant women in Addis Ababa, Ethiopia. Pharmacoepidemiology and Drug Safety 2009 18 6 462 468 2-s2.0-68149098922 10.1002/pds.1732
8. Olesen C., Sørensen H. T., de Jong-Van den Berg L., Olsen J., Steffensen F. H., Czeicel A., Nielsen G. L., de Jong L., Irgens L., Bergman U., Pedersen L., Lie R. T., de Vries C., Leurquin P., Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. Acta Obstetricia et Gynecologica Scandinavica 1999 78 8 686 692 2-s2.0-0032774301 (Pubitemid 29392672)
9. Osorio-de-Castro C. G., Pepe V. L., Luiza V. L., Cosendey M. A., Freitas A. M., Miranda F. F., Bermudez J. A., Leal M. C., Prescribed and reported drug use during pregnancy. Cadernos de Saúde Pública 2004 20 supplement 1 S73 82 2-s2.0-27744448797
10. Rohra D. K., Das N., Azam S. I., Solangi N. A., Memon Z., Shaikh A. M., Khan N. H., Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study. BMC Pregnancy and Childbirth 2008 8, article 24 2-s2.0-48649101310 10.1186/1471-2393-8-24
11. Daw J. R., Hanley G. E., Greyson D. L., Morgan S. G., Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiology and Drug Safety 2011 20 9 895 902 10.1002/pds.2184
12. Koren G., Pastuszak A., Ito S., Drugs in Pregnancy. New England Journal of Medicine 1998 338 16 1128 1137 2-s2.0-0032537137 10.1056/NEJM199804163381607 (Pubitemid 28227484)
13. Bánhidy F., Lowry R., Czeizel A., Risk and benefit of drug use during pregnancy. International Journal of Medical Sciences 2005 2 3 100 106 (Pubitemid 41074234)
14. Malm H., Martikainen J., Klaukka T., Neuvonen P. J., Prescription drugs during pregnancy and lactation-a Finnish register-based study. European Journal of Clinical Pharmacology 2003 59 2 127 133 2-s2.0-0038391387 (Pubitemid 36793725)
15. Food and Drug Administration, Code of Federal Regulations. Title 21, Vol. 4, 2012, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm? fr=201
16. Lacroix I., Damase-Michel C., Lapeyre-Mestre M., Montastruc J. L., Prescription of drugs during pregnancy in France. Lancet 2000 356 9243 1735 1736 2-s2.0-0034684421
17. Basgül A., Akici A., Uzuner A., Kalaça S., Kavak Z. N., Tural A., Oktay S., Drug utilization and teratogenicity risk categories during pregnancy. Advances in Therapy 2007 24 1 68 80 2-s2.0-34247868031 10.1007/BF02849994 (Pubitemid 46700867)
18. Andrade S., Raebel M., Morse A., Davis R., Chan K., Finkelstein J., Fortman K., McPhillips H., Roblin D., Smith D., Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiology and Drug Safety 2006 15 8 546 554 (Pubitemid 44336269)
19. Riley E. H., Fuentes-Afflick E., Jackson R. A., Escobar G. J., Brawarsky P., Schreiber M., Haas J. S., Correlates of prescription drug use during pregnancy. Journal of Women's Health 2005 14 5 401 409 2-s2.0-22944483169 10.1089/jwh.2005.14.401 (Pubitemid 41052038)
20. Daw J. R., Mintzes B., Law M. R., Hanley G. E., Morgan S. G., Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clinical Therapeutics 2012 34 1 239 249
21. Irl C., Hasford J., The PEGASUS project-a prospective cohort study for the investigation of drug use in pregnancy. International Journal of Clinical Pharmacology and Therapeutics 1997 35 12 572 576 2-s2.0-2642694704 (Pubitemid 28010386)
22. Malm H., Martikainen J., Klaukka T., Neuvonen P. J., Prescription of hazardous drugs during pregnancy. Drug Safety 2004 27 12 899 908 2-s2.0-4944264214 10.2165/00002018-200427120-00006 (Pubitemid 39331687)
23. Mengue S. S., Schenkel E. P., Duncan B. B., Schmidt M. I., Drug use by pregnant women in six Brazilian cities. Revista de Saude Publica 2001 35 5 415 420 2-s2.0-0035543140 (Pubitemid 34065339)
24. Barros A. J. D., dos Santos I. D. S., Victora C. G., Albernaz E. P., Domingues M. R., Timm I. K., Matijasevich A., Bertoldi A. D., Barros F. C., The 2004 Pelotas birth cohort: methods and description. Revista de Saude Publica 2006 40 3 402 413 2-s2.0-33847749497 10.1590/S0034-89102006000300007
25. Klasco R., DRUGDEX System. Thomson MICROMEDEX 2010
26. BRIGGS G. G., FREEMAN R. K., YAFFE S. J., Drugs in Pregnancy and Lactation 2011 9th Philadelphia Lippincott Williams & Wilkins
27. Haramburu F., Miremont-Salamé G., Moore N., Good and bad drug prescription in pregnancy. Lancet 2000 356 9243 1704 2-s2.0-0034684462
28. Yang T., Walker M. C., Krewski D., Yang Q., Nimrod C., Garner P., Fraser W., Olatunbosun O., Wen S. W., Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiology and Drug Safety 2008 17 3 270 277 2-s2.0-40949123220 10.1002/pds.1538 (Pubitemid 351404038)
29. de Jong-van den Berg L. T., Waardenburg C. M., Haaijer-Ruskamp F. M., Dukes M. N. G., Wesseling H., Drug use in pregnancy: a comparative appraisal of data collecting methods. European Journal of Clinical Pharmacology 1993 45 1 9 14 2-s2.0-0027234608 (Pubitemid 23225950)
30. Bertoldi A. D., Barros A. J. D., Hallal P. C., Lima R. C., Drug utilization in adults: prevalence and individuals determinants. Revista de Saude Publica 2004 38 2 228 238 2-s2.0-2942635102 (Pubitemid 38780032)
31. Carrasco-Garrido P., Jiménez-García R., Hernández Barrera V., Gil de Miguel A., Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiology and Drug Safety 2008 17 2 193 199 2-s2.0-39749192021 10.1002/pds.1455 (Pubitemid 351308519)
32. Sans S., Paluzie G., Puig T., Balana L., Balaguer-Vintro I. I., Prevalence of drug utilization in the adult population of Catalonia, Spain. Gaceta Sanitaria 2002 16 2 121 130
33. Costa K. S., de Barros M. B. A., Francisco P. M. S. B., César C. L. G., Goldbaum M., Carandina L., Use of medication and associated factors: a population-based study in Campinas, São Paulo State, Brazil. Cadernos de Saude Publica 2011 27 4 649 658 2-s2.0-79957668099
34. Egen-Lappe V., Hasford J., Drug prescription in pregnancy: analysis of a large statutory sickness fund population. European Journal of Clinical Pharmacology 2004 60 9 659 666 2-s2.0-11244258979 10.1007/s00228-004-0817-1 (Pubitemid 40064599)
35. Wiffen P., Mitchell M., Snelling M., Oxford Handbook of Clinical Pharmacy Oxford 2007 Oxford, UK Oxford University Press
36. Guerra G. C., da Silva A. Q., Franca L. B., Assuncao P. M., Cabral R. X., Ferreira A. A., Drug use during pregnancy in Natal, Brazil. Revista Brasileira de Ginecologia e Obstetrícia 2008 30 1 12 18
37. Addis A., Magrini N., Mastroiacovo P., Drug use during pregnancy. Lancet 2001 357 9258 800 10.1016/S0140-6736(05)71221-6 2-s2.0-0035836239
38. Shah P. S., Ohlsson A., Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. Canadian Medical Association Journal 2009 180 12 E99 E108 2-s2.0-67649194404 10.1503/cmaj.081777
39. Haider B. A., Bhutta Z. A., Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2006 4 2-s2.0-42749099914 10.1002/14651858.CD004905.pub2 CD004905 (Pubitemid 46841267)
40. Damase-Michel C., Lapeyre-Mestre M., Moly C., Fournié A., Montastruc J. L., Drug use during pregnancy: survey in 250 women consulting at a university hospital center. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 2000 29 1 77 85 2-s2.0-0034007825 (Pubitemid 30114984)
41. Peña-Rosas J. P., Viteri F. E., Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2009 4 CD004736 2-s2.0-75349110349
42. Feibus K. B., FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use. Journal of Medical Toxicology 2008 4 4 284 288 2-s2.0-60749104289
43. Holmes L. B., Human teratogens: update 2010. Birth Defects Research Part A 2011 91 1 1 7 2-s2.0-78751561105 10.1002/bdra.20748